NCT02431429View on ClinicalTrials.gov

Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 23, 2018

Study Completion Date

March 1, 2019

Conditions
Mucocutaneous Leishmaniasis
Interventions
DRUG

Miltefosine

Trial Locations (1)

Unknown

Funderama, Santa Cruz

Sponsors
All Listed Sponsors
lead

Knight Therapeutics (USA) Inc

INDUSTRY

NCT02431429 - Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis | Biotech Hunter | Biotech Hunter